SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "(WFRF:(Visser Pieter J.)) srt2:(2012-2014)"

Sökning: (WFRF:(Visser Pieter J.)) > (2012-2014)

  • Resultat 1-8 av 8
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Jacobs, Heidi I. L., et al. (författare)
  • The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
  • 2012
  • Ingår i: Neurobiology of Aging. - : Elsevier BV. - 1558-1497 .- 0197-4580. ; 33:1, s. 1-201
  • Tidskriftsartikel (refereegranskat)abstract
    • White matter hyperintensities (WMH) in Mild Cognitive Impairment (MCI) have been associated with impaired executive functioning, although contradictory findings have been reported. The aim of this study was to examine whether WMH location influenced the relation between WMH and executive functioning in MCI participants (55-90 years) in the European multicenter memory-clinic-based DESCRIPA study, who underwent MRI scanning at baseline (N = 337). Linear mixed model analysis was performed to test the association between WMH damage in three networks (frontal-parietal, frontal-subcortical and frontal-parietal-subcortical network) and change in executive functioning over a 3-year period. WMH in the frontal-parietal and in the frontal-parietal-subcortical network were associated with decline in executive functioning. However, the frontal-subcortical network was not associated with change in executive functioning. Our results suggest that parietal WMH are a significant contributor to executive decline in MCI and that investigation of WMH in the cerebral networks supporting cognitive functions provide a new way to differentiate stable from cognitive declining MCI individuals. (C) 2012 Elsevier Inc. All rights reserved.
  •  
2.
  • Blum, Johannes, et al. (författare)
  • LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.
  • 2014
  • Ingår i: Journal of Travel Medicine. - : Oxford University Press (OUP). - 1195-1982 .- 1708-8305. ; 21:2, s. 116-29
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Treatment of cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML) in travelers is still controversial. Over the last decade, national and international consortia have published recommendations for treating CL in travelers. These guidelines harmonize many issues, but there are some discrepancies.METHODS: Leishmania parasites causing CL can now be genotyped by polymerase chain reaction techniques for detecting Leishmania DNA. Therefore, treatment recommendations can now be species based rather than based on geographical exposure. To review the evidence on which the recommendations were based, "LeishMan" (Leishmaniasis Management), a group of experts from 13 institutions in eight European countries, performed a PubMed MEDLINE) literature search and considered unpublished evidence and the experts' own personal experiences. The Oxford evidence grading system was used to evaluate the information.RESULTS AND CONCLUSION: In this article, the authors provide practical treatment recommendations for imported CL and ML in Europe, drawn up from the review by the European experts.
  •  
3.
  • Damian, Marinella, et al. (författare)
  • Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
  • 2013
  • Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 36:1-2, s. 1-19
  • Tidskriftsartikel (refereegranskat)abstract
    • Background/Aims: To identify prodromal Alzheimer's disease (AD) subjects using a data-driven approach to determine cognitive profiles in mild cognitive impairment (MCI). Methods: A total of 881 MCI subjects were recruited from 20 memory clinics and followed for up to 5 years. Outcome measures included cognitive variables, conversion to AD, and biomarkers (e. g. CSF, and MRI markers). Two hierarchical cluster analyses (HCA) were performed to identify clusters of subjects with distinct cognitive profiles. The first HCA included all subjects with complete cognitive data, whereas the second one selected subjects with very mild MCI (MMSE >= 28). ANOVAs and ANCOVAs were computed to examine whether the clusters differed with regard to conversion to AD, and to AD-specific biomarkers. Results: The HCAs identified 4-cluster solutions that best reflected the sample structure. One cluster (aMCIsingle) had a significantly higher conversion rate (19%), compared to subjective cognitive impairment (SCI, p < 0.0001), and non-amnestic MCI (naMCI, p = 0.012). This cluster was the only one showing a significantly different biomarker profile (A beta(42), t-tau, APOE epsilon 4, and medial temporal atrophy), compared to SCI or naMCI. Conclusion: In subjects with mild MCI, the single-domain amnestic MCI profile was associated with the highest risk of conversion, even if memory impairment did not necessarily cross specific cut-off points. A cognitive profile characterized by isolated memory deficits may be sufficient to warrant applying prevention strategies in MCI, whether or not memory performance lies below specific z-scores. This is supported by our preliminary biomarker analyses. However, further analyses with bigger samples are needed to corroborate these findings. Copyright (C) 2013 S. Karger AG, Basel
  •  
4.
  • Dubois, Bruno, et al. (författare)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
  • 2014
  • Ingår i: Lancet neurology. - 1474-4465. ; 13:6, s. 614-29
  • Forskningsöversikt (refereegranskat)abstract
    • In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging-Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD) that better define clinical phenotypes and integrate biomarkers into the diagnostic process, covering the full staging of the disease. This Position Paper considers the strengths and limitations of the IWG research diagnostic criteria and proposes advances to improve the diagnostic framework. On the basis of these refinements, the diagnosis of AD can be simplified, requiring the presence of an appropriate clinical AD phenotype (typical or atypical) and a pathophysiological biomarker consistent with the presence of Alzheimer's pathology. We propose that downstream topographical biomarkers of the disease, such as volumetric MRI and fluorodeoxyglucose PET, might better serve in the measurement and monitoring of the course of disease. This paper also elaborates on the specific diagnostic criteria for atypical forms of AD, for mixed AD, and for the preclinical states of AD.
  •  
5.
  • Duits, Flora H., et al. (författare)
  • The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
  • 2014
  • Ingår i: Alzheimer's & Dementia. - : Elsevier. - 1552-5260 .- 1552-5279. ; 10:6, s. 713-723
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: We aimed to identify the most useful definition of the "cerebrospinal fluid Alzheimer profile," based on amyloid-beta(1-42) (A beta(42)), total tau, and phosphorylated tau (p-tau), for diagnosis and prognosis of Alzheimers disease (AD). Methods: We constructed eight Alzheimer profiles with previously published combinations, including regression formulas and simple ratios. We compared their diagnostic accuracy and ability to predict dementia due to AD in 1385 patients from the Amsterdam Dementia Cohort. Results were validated in an independent cohort (n = 1442). Results: Combinations outperformed individual biomarkers. Based on the sensitivity of the best performing regression formulas, cutoffs were chosen at 0.52 for the tau/A beta(42) ratio and 0.08 for the p-tau/A beta(42) ratio. Ratios performed similar to formulas (sensitivity, 91%-93%; specificity, 81%-84%). The same combinations best predicted cognitive decline in mild cognitive impairment patients. Validation confirmed these results, especially regarding the tau/A beta(42) ratio. Conclusions: A tau/A beta(42) ratio of greater than0.52 constitutes a robust cerebrospinal fluid Alzheimer profile. We recommend using this ratio to combine biomarkers.
  •  
6.
  • Gerritsen, Bart H. M., et al. (författare)
  • Social Media Coming to the Mall : A Cross-Channel Response
  • 2014. - 1
  • Ingår i: <em></em>Product Development in the Socio-sphere. - Cham : Springer. - 9783319074030 - 9783319074047 ; , s. 169-235
  • Bokkapitel (refereegranskat)abstract
    • Traditional shopping malls experience the effects of expanding online shopping. In addition, social media grew as a platform for customer orientation and expression. In-mall retail must respond. We take the customer journey as the guiding model for customer experience building and focus on converting cross-channel built customer expectation into enriched customer experiences in in-mall stores. We focus on the in-mall part of the journey but recognize the need to engage with customers in other parts of the journey and on social media. That is where the word-of-mouth spreads nowadays. We develop a ‘u-retail’ process model and a cyber-physical system concept for a mall: we combine a mall website, mobile apps and interactive storefronts containing Facebook processes into an integrating system. Customers can manipulate info and processes displayed on the interactive storefront through touch or mobile devices. The Facebook shopping-with-online-friends process inserts real-time feedback from social media friends in the storefront window. We show how ‘gamification’ and trust and loyalty breeding can be employed. Mall and retailers attract customers in a collective manner, from parking services to package deals. Cross-channel customer tracking is part of the concept, providing a view on both online and offline communities. Ubiquitous tracking of customers foster deep customer relation and experience of data. We implemented a first partly surrogate prototype to validate the concept. This partly empirical, partly designed experimental implementation can itself be a big data tool for scientists and retailers to acquire deeper insights. The concept can be generalized to other social contexts. © Springer International Publishing Switzerland 2014
  •  
7.
  • van Rossum, Ineke A, et al. (författare)
  • Injury markers predict time to dementia in subjects with MCI and amyloid pathology.
  • 2012
  • Ingår i: Neurology. - 1526-632X. ; 79:17, s. 1809-16
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer disease (AD) can now be diagnosed in subjects with mild cognitive impairment (MCI) using biomarkers. However, little is known about the rate of decline in those subjects. In this cohort study, we aimed to assess the conversion rate to dementia and identify prognostic markers in subjects with MCI and evidence of amyloid pathology.
  •  
8.
  • Vermeiren, Angelique P. A., et al. (författare)
  • The Association Between APOE epsilon 4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study
  • 2013
  • Ingår i: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 35:2, s. 241-246
  • Tidskriftsartikel (refereegranskat)abstract
    • We assessed the interaction between the APOE epsilon 4 allele and education level in the etiology of Alzheimer's disease (AD) among memory clinic patients from the multicenter DESCRIPA study. Subjects (n = 544) were followed for 1 to 5 years. We used Cox's stratified survival modeling, adjusted for age, gender, and center. APOE epsilon 4 predicted the onset of AD-type dementia in middle (HR 3.45 95% CI 1.79-6.65, n = 222) and high (HR 3.67 95% CI 1.36-9.89, n = 139) but not in low educated subjects (HR 0.81, 95% CI 0.38-1.72, n = 183). This suggests that mechanisms in developing Alzheimer-type dementia may differ between educational groups that raises questions related to Alzheimer-type dementia prevention.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-8 av 8
Typ av publikation
tidskriftsartikel (6)
forskningsöversikt (1)
bokkapitel (1)
Typ av innehåll
refereegranskat (8)
Författare/redaktör
Scheltens, Philip (6)
Hampel, Harald (6)
Minthon, Lennart (5)
Tsolaki, Magda (5)
Visser, Pieter Jelle (5)
Wahlund, Lars-Olof (4)
visa fler...
Soininen, Hilkka (4)
Frisoni, Giovanni B. (4)
Blennow, Kaj, 1958 (3)
Vellas, Bruno (3)
van der Flier, Wiesj ... (2)
Teunissen, Charlotte ... (2)
Jones, Roy W. (2)
Almkvist, Ove (1)
Zetterberg, Henrik, ... (1)
Boada, Mercè (1)
Aarsland, Dag (1)
Pasquier, Florence (1)
Wallin, Anders, 1950 (1)
Olde Rikkert, Marcel (1)
Dorlo, Thomas P C (1)
Marcusson, Jan (1)
Solberg Søilen, Klau ... (1)
Winblad, Bengt (1)
Hansson, Oskar (1)
Barkhof, Frederik (1)
Molinuevo, José Luis (1)
Zeegers, Maurice P. (1)
Fox, Nick C (1)
Ewers, Michael (1)
Nordberg, Agneta (1)
Graff, Caroline (1)
Andreasen, Niels (1)
Engelborghs, Sebasti ... (1)
Parnetti, Lucilla (1)
Mattsson, Niklas, 19 ... (1)
Caumes, Eric (1)
Rueckert, Daniel (1)
Gauthier, Serge (1)
Stern, Yaakov (1)
Habert, Marie-Odile (1)
Dubois, Bruno (1)
Epelbaum, Stéphane (1)
Salloway, Stephen (1)
Cummings, Jeffrey L. (1)
Nobili, Flavio (1)
Kehoe, Patrick (1)
Visser, Leo (1)
de Leon, Mony J. (1)
Galasko, Douglas (1)
visa färre...
Lärosäte
Karolinska Institutet (6)
Lunds universitet (5)
Göteborgs universitet (3)
Uppsala universitet (1)
Högskolan i Halmstad (1)
Stockholms universitet (1)
visa fler...
Linköpings universitet (1)
visa färre...
Språk
Engelska (8)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (7)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy